Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$213.86 - $277.87 $485,676 - $631,042
-2,271 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$259.82 - $298.18 $1.85 Million - $2.12 Million
-7,103 Reduced 75.77%
2,271 $599,000
Q4 2021

Feb 11, 2022

BUY
$271.6 - $314.21 $1.89 Million - $2.19 Million
6,973 Added 290.42%
9,374 $2.95 Million
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $659,842 - $740,324
2,401 New
2,401 $676,000
Q3 2019

Nov 14, 2019

SELL
$159.77 - $178.1 $111,839 - $124,670
-700 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$123.7 - $156.3 $44,532 - $56,268
-360 Reduced 33.96%
700 $107,000
Q4 2018

Feb 14, 2019

SELL
$120.82 - $174.09 $12,927 - $18,627
-107 Reduced 9.17%
1,060 $134,000
Q2 2018

Aug 14, 2018

BUY
$160.33 - $189.41 $187,105 - $221,041
1,167 New
1,167 $210,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $18.2B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Trustmark National Bank Trust Department Portfolio

Follow Trustmark National Bank Trust Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustmark National Bank Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Trustmark National Bank Trust Department with notifications on news.